<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:ns1="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001085146-21-002223</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001771605</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>01/29/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001796129</issuerCik>
        <issuerName>Vincerx Pharma, Inc.</issuerName>
        <issuerCusip>92731L106</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <ns1:street1>260 SHERIDAN AVENUE</ns1:street1>
          <ns1:street2>SUITE 400</ns1:street2>
          <ns1:city>PALO ALTO</ns1:city>
          <ns1:stateOrCountry>CA</ns1:stateOrCountry>
          <ns1:zipCode>94306</ns1:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Sage Rhino Capital, LLC</reportingPersonName>
      <citizenshipOrOrganization>CA</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4260</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4260</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Vincerx Pharma, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>260 SHERIDAN AVENUE, SUITE 400, PALO ALTO, CALIFORNIA
94306</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Sage Rhino Capital, LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>101 Jefferson Drive
Menlo Park, CA
94025</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Sage Rhino Capital, LLC - CALIFORNIA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>4,260</amountBeneficiallyOwned>
        <classPercent>0</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Sage Rhino Capital, LLC - 4,260</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Sage Rhino Capital, LLC - 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Sage Rhino Capital, LLC - 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Sage Rhino Capital, LLC - 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>N</notApplicableFlag>
        <groupDissolutionNotice>VINCERX Pharma is pending dissolution.</groupDissolutionNotice>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Sage Rhino Capital, LLC</reportingPersonName>
      <signatureDetails>
        <signature>Dana Franco Young</signature>
        <title>Chief Compliance Officer</title>
        <date>07/28/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
